Bengaluru-based drug maker Strides Shasun has agreed to sell its domestic branded formulations business to Ahmedabad-based Eris Lifesciences for Rs 500 crore, joining a select league of Indian pharmaceuticals firms...
Fortis to buy realty assets back from RHT for Rs 4,650 crore
Fortis HealthcareBSE -3.35 % will buy back the real estate assets that house its 14 existing hospitals and four upcoming projects from Religare Healthcare Trust (RHT) for Rs 4,650 crore, including Rs 1,152 crore of debt...
Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics market
Indian pharmaceutical firm Morepen LaboratoriesBSE 3.37 % Ltd, listed on the Bombay Stock Exchange, has inked an exclusive agreement to market and distribute Belgian probiotics player Vesale Pharma International’s...
ET Analysis: With Unichem Buy, Torrent’s new M&A star in pharma
The Torrent-Unichem deal did not really surprise the pharma industry. The 73-year-old Mumbai-based UnichemBSE -2.24 % had been an attractive and an obvious target in the domestic formulations market for some years now...
Torrent Pharma walks away with Unichem’s domestic business for Rs 3,600 crore
Torrent Pharma is acquiring the domestic business of Unichem Laboratories for Rs 3,600 crore in a deal that will make the Ahmedabad-based company among the country’s top five drugmakers. The deal will also give Torrent...
Teva in talks to set up joint venture with China’s Guangzhou Pharma
Teva Pharmaceutical Industries Ltd is making its boldest move in China with plans to set up a joint venture with Guangzhou Pharmaceutical Holdings Ltd to make and sell the Israeli company’s generic drugs in the world’s...
Torrent to buy Unichem’s domestic biz for Rs 3,500 cr; announcement today
Ahmedabad-headquartered pharmaceutical giant Torrent Pharmaceuticals is likely to announce the acquisition of Unichem Laboratories’ domestic business for a consideration of about Rs 3,500 crore after market hours...
Alembic Pharma arm acquires US-based Orit Lab
Vadodara-based Alembic Pharmaceuticals Ltd on Wednesday announced that it had acquired US-based generic drug developer Orit Laboratories LLC through its 100 percent subsidiary Alembic Pharmaceuticals Inc. As per...
Intas closing in on Mallinckrodt’s US generics business
Intas Pharmaceuticals, backed by Temasek and ChrysCapital, has inched closer to arguably the biggest cross-border buyout by an Indian pharma company, emerging as the front-runner to acquire Mallinckrodt’s generics drug...
Novartis to buy French cancer specialist AAA for $3.9 billion
Novartis has agreed to buy French-based Advanced Accelerator Applications (AAA) for $3.9 billion, giving it a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Steve Jobs...
Torrent Pharma in advanced talks to buy Unichem’s India business for Rs3,200-3,300 crore
Torrent Pharmaceuticals Ltd is likely in advanced discussions to acquire the domestic formulations business of Unichem Laboratories Ltd for Rs3,200-3,300 crore, two people aware of the development said on the condition...
Fosun Pharma to buy France’s Tridem for $73 million
Shanghai Fosun Pharmaceutical (Group) Co. Ltd said it would buy French drug distributor Tridem Pharma S.A.S. for €63 million ($73 million), in a move to expand its market share in Europe and Africa. The Chinese drug...
